[1]
V. Aprilia, Sarmoko, M. S. Fareza, H. N. Baroroh, and N. A. Choironi, “Evaluation of natural compounds as VEGFR-2 inhibitors for breast cancer therapy: insights from molecular docking and drug-likeness analysis”, Pharm.Rep., vol. 4, no. 2, p. 82, Oct. 2024.